We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+2.77%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$11.3B
AUM Growth
-$128M
Cap. Flow
-$697M
Cap. Flow %
-6.16%
Top 10 Hldgs %
41.41%
Holding
1,243
New
52
Increased
320
Reduced
317
Closed
40

Top Buys

Rank Stock Value
1
HST icon
Host Hotels & Resorts
HST
+$98.9M
2
PSA icon
Public Storage
PSA
+$78.4M
3
MAC icon
Macerich
MAC
+$57.8M
4
VICI icon
VICI Properties
VICI
+$56M
5
EQR icon
Equity Residential
EQR
+$46.3M

Top Sells

Rank Stock Value
1
DLR icon
Digital Realty Trust
DLR
+$144M
2
AMT icon
American Tower
AMT
+$112M
3
LSI
Life Storage, Inc.
LSI
+$105M
4
CUZ icon
Cousins Properties
CUZ
+$69.4M
5
DOC icon
Healthpeak Properties
DOC
+$67.5M

Sector Composition

Rank Sector Weight
1 Real Estate 72.31%
2 Technology 4.13%
3 Industrials 3.02%
4 Financials 2.93%
5 Healthcare 2.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
QTRX icon
1076
Quanterix
QTRX
$173M
$5K ﹤0.01%
141
– –
RYTM icon
1077
Rhythm Pharmaceuticals
RYTM
$7B
$5K ﹤0.01%
219
– –
TVTX icon
1078
Travere Therapeutics
TVTX
$5.33B
$5K ﹤0.01%
263
– –
URGN icon
1079
UroGen Pharma
URGN
$2B
$5K ﹤0.01%
150
– –
VNDA icon
1080
Vanda Pharmaceuticals
VNDA
$312M
$5K ﹤0.01%
335
– –
ZLAB icon
1081
Zai Lab
ZLAB
$2.17B
$5K ﹤0.01%
132
– –
QTTB icon
1082
Q32 Bio
QTTB
$450M
$5K ﹤0.01%
13
– –
TVRD
1083
Tvardi Therapeutics
TVRD
$23.5M
$5K ﹤0.01%
7
– –
EGRX
1084
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$5K ﹤0.01%
82
– –
DCPH
1085
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$5K ﹤0.01%
240
– –
CLVS
1086
DELISTED
Clovis Oncology, Inc.
CLVS
$5K ﹤0.01%
336
– –
AKBA icon
1087
Akebia Therapeutics
AKBA
$327M
$4K ﹤0.01%
740
– –
AUPH icon
1088
Aurinia Pharmaceuticals
AUPH
$1.97B
$4K ﹤0.01%
577
+113
+24% +$720
CRNX icon
1089
Crinetics Pharmaceuticals
CRNX
$8.86B
$4K ﹤0.01%
153
– –
CYTK icon
1090
Cytokinetics
CYTK
$11B
$4K ﹤0.01%
363
+65
+22% +$627
LXRX icon
1091
Lexicon Pharmaceuticals
LXRX
$1.02B
$4K ﹤0.01%
583
– –
RCKT icon
1092
Rocket Pharmaceuticals
RCKT
$348M
$4K ﹤0.01%
276
– –
TXMD icon
1093
TherapeuticsMD
TXMD
$23.8M
$4K ﹤0.01%
31
– –
ITCI
1094
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$4K ﹤0.01%
302
– –
RVNC
1095
DELISTED
Revance Therapeutics, Inc.
RVNC
$4K ﹤0.01%
280
– –
PETQ
1096
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
$4K ﹤0.01%
136
– –
TBIO
1097
DELISTED
Translate Bio, Inc. Common Stock
TBIO
$4K ﹤0.01%
287
– –
AKRX
1098
DELISTED
Akorn Inc
AKRX
$4K ﹤0.01%
+792
New +$3.05K
BCRX icon
1099
BioCryst Pharmaceuticals
BCRX
$2.37B
$3K ﹤0.01%
697
– –
CRBP icon
1100
Corbus Pharmaceuticals
CRBP
$170M
$3K ﹤0.01%
14
+4
+40% +$856
42 43
44
45 46

Similar funds

SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Daiwa Securities Group's Q2 2019 Portfolio in Review

As of Q2 2019, Daiwa Securities Group held 1,243 positions worth $11.3B, down 1.1% from $11.4B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Daiwa Securities Group withdrew a net $697M in Q2 2019, closing 40 positions and reducing 317 holdings. Its most notable exit was L3Harris, an estimated $3.77M position sold in full.

By sector, the portfolio is most concentrated in Real Estate at 72% of assets, down from 74% a quarter earlier, followed by Technology and Industrials.

Against the trend, Daiwa Securities Group opened a new position in Coupa Software Incorporated worth $4.17M.

  • Daiwa Securities Group's largest Q2 2019 buy was Coupa Software Incorporated: 32,900 shares worth $4.17M.
  • Daiwa Securities Group added most to Host Hotels & Resorts in Q2 2019, an estimated $98.9M increase.
  • Daiwa Securities Group's biggest Q2 2019 reduction was Digital Realty Trust, cutting an estimated $144M.
  • Daiwa Securities Group fully exited L3Harris in Q2 2019, selling an estimated $3.77M.
  • Daiwa Securities Group's ten largest holdings make up 41% of its $11.3B portfolio in Q2 2019.
  • Daiwa Securities Group opened 52 new positions and closed 40 in Q2 2019.
  • Daiwa Securities Group's portfolio value fell 1.1% quarter-over-quarter to $11.3B.

Based on Daiwa Securities Group's 13F filing for Q2 2019, filed 24 Jul 2019.